IRIS
AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.711
AS - Asia 1.927
NA - Nord America 1.749
SA - Sud America 224
AF - Africa 62
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.678
Salva come PNG Salva come JPEG
Nazione #
NL - Olanda 3.761
US - Stati Uniti d'America 1.660
RU - Federazione Russa 805
SG - Singapore 729
IT - Italia 457
CN - Cina 369
HK - Hong Kong 323
VN - Vietnam 210
BR - Brasile 176
DE - Germania 143
IE - Irlanda 111
FR - Francia 110
GB - Regno Unito 94
ID - Indonesia 56
BD - Bangladesh 51
CA - Canada 47
SE - Svezia 41
IN - India 36
ES - Italia 31
MX - Messico 31
BJ - Benin 27
FI - Finlandia 27
UA - Ucraina 27
KR - Corea 26
PL - Polonia 21
IQ - Iraq 17
CZ - Repubblica Ceca 16
AR - Argentina 15
AT - Austria 15
JP - Giappone 15
TR - Turchia 14
ZA - Sudafrica 14
CH - Svizzera 13
PK - Pakistan 12
JO - Giordania 11
LT - Lituania 8
VE - Venezuela 8
BE - Belgio 7
EC - Ecuador 7
MD - Moldavia 6
DZ - Algeria 5
IL - Israele 5
MY - Malesia 5
RO - Romania 5
TH - Thailandia 5
TW - Taiwan 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
CO - Colombia 4
CR - Costa Rica 4
GR - Grecia 4
IR - Iran 4
MA - Marocco 4
PH - Filippine 4
UZ - Uzbekistan 4
BG - Bulgaria 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
MU - Mauritius 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 9.678
Salva come PNG Salva come JPEG
Città #
Amsterdam 3.745
Hong Kong 322
Singapore 296
San Jose 223
Council Bluffs 194
Ashburn 170
Beijing 121
Dublin 111
St Louis 86
New York 79
Los Angeles 76
Lauterbourg 74
Turin 71
Moscow 68
Milan 62
Hanoi 55
Ho Chi Minh City 51
Jakarta 44
Munich 41
Vercelli 34
Novara 33
Jacksonville 30
Orem 29
Buffalo 28
São Paulo 28
Cotonou 27
Frankfurt am Main 27
Boardman 26
Santa Clara 24
Columbus 21
London 21
Warsaw 21
Manchester 20
Chicago 18
Seoul 18
Chennai 17
Dallas 17
Falkenstein 17
Mexico City 17
Atlanta 16
Brno 16
Brooklyn 16
Chandler 16
Nuremberg 16
Genoa 15
Montreal 14
Tokyo 14
Dearborn 13
Rome 13
Stockholm 13
Toronto 13
Denver 12
Helsinki 12
Poplar 12
Amman 11
Houston 11
Phoenix 11
Ankara 9
Omaha 9
San Francisco 9
Da Nang 8
Rio de Janeiro 8
Vienna 8
Baghdad 7
Biên Hòa 7
Boston 7
Haiphong 7
Johannesburg 7
Las Vegas 7
Bologna 6
Borgomanero 6
Brasília 6
Guangzhou 6
Lawrence 6
Princeton 6
Shanghai 6
Tianjin 6
Tornaco 6
Wilmington 6
Alessandria 5
Belo Horizonte 5
Bexley 5
Guarulhos 5
Hillsboro 5
Mumbai 5
Petaling Jaya 5
Querétaro 5
San Mateo 5
Valencia 5
Zurich 5
Can Tho 4
City of London 4
Como 4
Dhaka 4
Guayaquil 4
Hangzhou 4
Hải Dương 4
Naples 4
New Delhi 4
Philadelphia 4
Totale 6.854
Salva come PNG Salva come JPEG
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.974
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.968
Bi-directional crosstalk between NAD/NAMPT and IFN-γ/PD-L1axes in melanoma 179
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 149
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 134
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 133
NAMPT in drug-resistant melanoma: linking NAMPT-dependent metabolic reprogramming and immune regulation 128
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 123
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 118
NAMPT inhibition impairs mTOR-dependent regulation of translation in melanomaNAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma. 116
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 115
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma 112
NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment 108
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms 103
The Extracellular NADome Modulates Immune Responses 103
Investigating the presence of eNAMPT/visfatin in human skimmed milk and milk fat globule membrane before and after Holder pasteurization. 98
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 97
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 94
Immunological method and kit for in vitro diagnosis of tumor and/or inflammatory diseases 89
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 89
Procedimento immunologico e kit per la diagnosi in vitro di patologie tumorali e/o infiammatorie 86
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 82
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 81
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 79
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 78
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 76
Impact of Holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk 76
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 75
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 75
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 74
NAMPT AND AUTOANTIBODIES: A POSSIBLE ASSOCIATION FOR AUTOIMMUNE DIAGNOSTICS? 72
The hidden life of NAD+-consuming ectoenzymes in the endocrine system 72
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 72
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network 70
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 70
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 69
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 69
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 68
NAMPT: A critical driver and therapeutic target for cancer 68
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 67
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 66
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 66
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 66
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 63
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES 62
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle 60
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 60
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 58
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 57
Translational reprogramming in BRAF inhibitors resistant melanoma: the impact of NAMPT/NAD metabolism in mTOR-dependent regulation of protein synthesis. 57
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets" 57
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 57
Effects of Ether Perfluoro Carboxyl Acids (PFECAs) on Innate Immunity in Earthworms (Eisenia fetida) 56
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 56
CD38 in chronic lymphocytic leukemia: from bench to bedside? 56
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 56
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 55
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 53
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 52
Editorial: Metabolic reprogramming in cancer 51
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 51
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 47
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 47
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 47
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 46
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 46
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 44
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 43
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 43
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 42
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia 42
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 41
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics 41
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 40
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 39
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 39
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 39
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 38
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options 37
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model 35
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 35
Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells 34
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting 34
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 31
PRO-INFLAMMATORY ROLE OF EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN CYSTIC FIBROSIS 29
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 29
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 27
null 23
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma 15
Secondary amide derivatives of Fe(III)-CDTA: Impact of ligand substitution on relaxivity, stability, and kinetic inertness 13
Totale 9.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 4 1 1 0 2 2 1 5 4 8
2022/2023197 6 5 7 2 3 17 3 12 119 6 9 8
2023/2024389 13 26 32 18 62 4 86 33 6 5 22 82
2024/20251.346 46 5 119 34 92 54 177 91 456 53 56 163
2025/20267.716 167 153 171 403 416 340 508 597 4.035 418 280 228
Totale 9.790